Amplify Weight Loss Drug & Treatment ETF
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell THNR and other ETFs, options, and stocks.About THNR
THNR tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses.
What's in this fund
Sectors
As of January 14, 2026Top 10 Holdings (71.40% of total assets)
As of January 14, 2026THNR Key Statistics
Stock Snapshot
As of today, Amplify Weight Loss Drug & Treatment ETF(THNR) shares are valued at $25.94. The company's market cap stands at 3.9M, with a P/E ratio of 23.43 and a dividend yield of 1.7%.
On 2026-01-18, Amplify Weight Loss Drug & Treatment ETF(THNR) stock traded between a low of $25.80 and a high of $25.94. Shares are currently priced at $25.94, which is +0.5% above the low and 0.0% below the high.
Amplify Weight Loss Drug & Treatment ETF(THNR) shares are trading with a volume of 1.38K, against a daily average of 1.39K.
In the last year, Amplify Weight Loss Drug & Treatment ETF(THNR) shares hit a 52-week high of $26.44 and a 52-week low of $18.56.
In the last year, Amplify Weight Loss Drug & Treatment ETF(THNR) shares hit a 52-week high of $26.44 and a 52-week low of $18.56.